Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ 8x"d/D
a%
!XLyq
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© zl\#n:|
8:% R|b
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ?~.&Y
fYy.>m+P1
1.Co-stimulators (or co-stimulating molecules) ^WD$
gd
}^[@m#
2.NK-kB
A232"p_
jyhzLu
3.Immunoglobulin superfamily W~3tQ!
(OB8vTRXP
4.antigen-presenting cell (APC) pXv[]v
Jt6J'MOq
5.death domain 3\r@f_p
0@lC5-=
6.CCR and CXCR su
FOc
"5:f{GfO#v
7.Lectin (or mitogen) K<6x4ha
Lc<xgN+cJ
8.Clusters of differentiation, CD) *"FLkC4
%:KV2GP
9.B7 family !`[I>:Ex
_F@p53WE
10.Cytotoxic T lymphocyte, CTL) :ZS8Zm"
6^O?p2xpo
11.IL-15 and IL-15 receptor (IL-15R) Hu8atlpo
*}ee"eHs
12.MHC restriction ^FM9} t/U,
@:+n6
13.Affinity-chromatography ynZ[c8.
C6UMc}
9h
14.Cyctosprin A, CsA '$h@
OI_/7@L
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) BX(d"z b<
N~;
khS]
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© `JWYPsWk
Eqm
v`Z
[_
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 ;q,)NAr&
e*2&s5 #RT
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ Mj
B<\g>
$wYuH9(
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ I0w@
S7
vN,}aV2nq
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© 5<O61Lgx
ok3
ÃâÒßѧרҵ£º ECS<l*i57&
adO!Gs9f?
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ RZd4(7H=q
g/l0}%
Ïû»¯ÄÚ¿Æ£º o7Cnyy#:
)-.Cne;n
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ fmnRUN=
BK(pJNBh
ѪҺ²¡Ñ§×¨Òµ£º }+{*, z
@cu}3>
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿